Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000702943 | SCV000831820 | pathogenic | Nephronophthisis | 2022-10-14 | criteria provided, single submitter | clinical testing | This variant is present in population databases (rs765263671, gnomAD 0.009%). For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 579607). This premature translational stop signal has been observed in individual(s) with nephronophthisis (PMID: 18076122). This sequence change creates a premature translational stop signal (p.Arg347*) in the NPHP1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NPHP1 are known to be pathogenic (PMID: 23559409). |
Ce |
RCV001200637 | SCV001371646 | pathogenic | not provided | 2020-06-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002507229 | SCV002782119 | pathogenic | Joubert syndrome with renal defect; Nephronophthisis 1; Senior-Loken syndrome 1 | 2022-05-03 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003472242 | SCV004191354 | pathogenic | Joubert syndrome with renal defect | 2024-02-29 | criteria provided, single submitter | clinical testing |